Cambridge Angels group
VC Fund
Cambridge, United Kingdom
Cambridge Angels group is a VC fund in Cambridge focused on Software and Health Care. The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
- Total investments:
- 139
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Cambridge Angels group invests in
Stages Cambridge Angels group invests in
Countries Cambridge Angels group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $382k–$3M
- Series A
- $2M–$9.5M
Investment Focus
Industry
- Software 25 (18%)
- Health Care 24 (17%)
- Biotechnology 22 (16%)
- Artificial Intelligence 15 (11%)
- Internet 10 (7%)
Stage
- Seed 63 (45%)
- Funding Round 18 (13%)
- Series A 16 (12%)
- Pre-Seed 11 (8%)
- Series B 6 (4%)
Country
- United Kingdom 97 (70%)
- United States 7 (5%)
- Estonia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Cleevely
CoFounder
|
CoFounder | Total investments: 7 | Find email | |
David Rowan
Angel Investor
|
Angel Investor | Total investments: 25 | Find email | |
Doug Richard
Founder
|
Founder | Total investments: 1 | Find email | |
Pete Hutton
Angel Investor
|
Angel Investor | Total investments: 7 | Find email | |
Ray Anderson
Founder Member
|
Founder Member | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Orthofuse
|
Orthofuse is a medtech company that provides orthopaedic solutions using 3D-printed implant systems designed to improve the safety and efficiency of surgical procedures. | $3M / Seed / Feb 12, 2026 | |
xWatts
|
xwatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions. | $2.2M / Seed / Feb 10, 2026 | |
MNS
|
MNS is a UK-based medical technology company developing Miracus, a proprietary needle-free drug delivery platform designed to replace traditional hypodermic injections with a painless, thermally stable patch. | Seed / Nov 26, 2025 | |
AVIEL Intelligence
|
AVIEL Intelligence provides a proactive, AI-driven solution to prevent customers from making payments to scammers and block fraudulent transactions. | $466.2K / Pre-Seed / Apr 30, 2025 | |
FLIT
|
FLIT specializes in the design and manufacturing of lightweight folding electric bikes (e-bikes) tailored for urban commuters. | $1.5M / Feb 17, 2025 | |
Wilder Sensing
|
Wilder Sensing is a nature technology business that uses artificial intelligence to quantify biodiversity changes. | $887.4K / Pre-Seed / Dec 12, 2024 | |
Illumion
|
Illumion is a company focused on transforming energy storage using light. Illumion aims to revolutionize how energy is stored and transferred by utilizing light to enhance the efficiency and performance of energy storage systems. | $2.7M / Seed / Dec 04, 2024 | |
|
xWatts
|
xwatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions. | $1.8M / Pre-Seed / Jul 18, 2024 | |
Monument Therapeutics
|
Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system. | $1.2M / Venture - Series Unknown / Apr 18, 2024 | |
Qureight
|
Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer. | $8.5M / Series A / Apr 16, 2024 | |
| See all 139 investments → | |||
Co-Investors
Martlet Capital
28 deals together
University of Cambridge Enterprise
19 deals together
Cambridge Capital Group
17 deals together
Parkwalk Advisors
16 deals together
IQ Capital
12 deals together
SyndicateRoom
11 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cambridge Angels group invest in?
Cambridge Angels group invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 139 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cambridge Angels group's check size?
Cambridge Angels group typically joins rounds of $382k–$3M at Seed and $2M–$9.5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cambridge Angels group participates in.
How do I contact Cambridge Angels group?
Public channels for Cambridge Angels group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cambridge Angels group?
The team at Cambridge Angels group includes David Cleevely (CoFounder), David Rowan (Angel Investor) and Doug Richard (Founder), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
